Brief report
Outcomes of anticoagulated trauma patients

https://doi.org/10.1016/S0735-6757(99)90050-5Get rights and content

Abstract

Patients on warfarin are at high risk for potentially life-threatening hemorrhage even after relatively minor trauma. Outcomes of these patients and the potential complications of reversing the effects of anticoagulation have received little attention. This study was performed to determine the overall outcome of orally anticoagulated patients who sustained injury as well as to determine any untoward effects of reversing their anticoagulated states. A retrospective study of injured patients on warfarin was conducted on patients admitted to an urban, university, tertiary-referral, level I trauma center between 1/1/93 and 12/31/96. Surviving patients were followed for a period of at least 1 month. Injuries were grouped by anatomic site. Charts were reviewed for degree of anticoagulation on admission (ie, initial international normalized ratio [INR]), survival, adverse effects of reversal of anticoagulation, and reinstitution of warfarin therapy. Discharged patients were contacted at home for follow-up. Thirty-five consecutive patients, 18 men and 17 women, on warfarin therapy at the time of their injuries were reviewed. The mean age was 75 years, with a range of 39 to 96. The mean follow-up period was 12.7 months. Reasons for anticoagulation included atrial fibrillation, prosthetic heart valves, revascularized limb, hypercoagulable state, deep venous thrombosis, pulmonary embolism, phlebitis, and aortic stenosis. Mean admission INR was 3.2, with a range of 1.6 to 10.0. There were 8 in-hospital deaths. Intracranial hemorrhages accounted for the majority of injuries. Ten patients were not given reversal therapy. Four complications were attributable to reversal therapy (upper extremity hemiplegia, transient ischemic attack, deep venous thrombosis, arterial thrombosis). Twenty-one patients had their warfarin reinstituted. Follow-up of surviving patients ranged from 1.5 to 42 months. Patients on warfarin are at high risk for intracranial hemorrhage following trauma. Patients on warfarin may be reversed during the acute period following injury, but transient complications may arise. Further prospective studies need to be conducted to determine which anticoagulated trauma patients may not require reversal therapy.

References (13)

There are more references available in the full text version of this article.

Cited by (45)

  • The risk of delayed intracranial hemorrhage with direct acting oral anticoagulants after trauma: A two-center study

    2019, American Journal of Surgery
    Citation Excerpt :

    In fact, the use of these agents has now surpassed the use of vitamin K antagonists in the United Kingdom and Canada.7,8 Pre-admission anticoagulants may lead to an increased risk for bleeding and other complications following trauma.9 For traumatic brain injuries (TBI) in particular, the use of warfarin prior to admission is associated with an increased risk for injury progression leading to increased mortality, especially in the elderly.10–12

  • Is There a Need for Platelet Transfusion After TBI in Patients on P2Y12 Inhibitors?

    2019, Journal of Surgical Research
    Citation Excerpt :

    The greatest fear of these medications is the risk of traumatic brain injury (TBI) and the devastating consequences of intracranial hemorrhage (ICH). Most of the previous studies have demonstrated a higher risk of progression of ICH and worse outcomes in patients on antiplatelet therapy who sustain a TBI.3-9 Aspirin is the classic antiplatelet agent and its risk of ICH has been extensively studied in the literature.10,11

  • Head and Neck Injuries: Special Considerations in the Elderly Patient

    2018, Neuroimaging Clinics of North America
    Citation Excerpt :

    Current clinical guidelines recommend head CT immediately after admission for all anticoagulated patients with head trauma.1,26 Once intracranial injury has been identified, immediate reversal of coagulopathy is generally warranted despite the potential complications resulting from reversal therapy (including thrombosis and volume overload).1,27,28 A follow-up CT is performed 6 hours after initial diagnosis to evaluate for stability, unless neurologic deterioration prompts earlier reevaluation (Fig. 5).

  • Antithrombotic agents intake prior to injury does not affect outcome after a traumatic brain injury in hospitalized elderly patients

    2017, Journal of Clinical Neuroscience
    Citation Excerpt :

    Benefits of chronic anticoagulation have been documented in some clinical population [7,8] but there is still a lack of consensus regarding the risks of this medication in TBI patients. There are some studies which suggested that mortality and morbidity in elderly patients taking anticoagulation medication is worse than without this pharmacological treatment before trauma [9,10]. A recent study has demonstrated that normalization of International Normalized Ratio (INR) was associated with decreased mortality in isolated TBI patients with acute traumatic anticoagulopathy [11].

  • The Efficacy of Recombinant Activated Factor VII in Severe Trauma

    2009, Annals of Emergency Medicine
    Citation Excerpt :

    To remain focused on a patient population that might be considered for treatment with rFVIIa, we addressed specific patient characteristics, including preexisting coagulopathy, mechanism of injury, and severity of injury. We excluded studies that focused on patients with preexisting hypocoagulable states such as hemophilia or patients receiving warfarin because of their biological uniqueness.1,7-10 rFVIIa is licensed and in wide use in patients with hemophilia with inhibitory alloantibodies to factor VIII.1

View all citing articles on Scopus

Presented at the 1997 American College of Emergency Physicians Research Forum, October 18, 1997, San Francisco, CA.

View full text